Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People who have been diagnosed with moderate-to-severe chronic kidney disease (CKD stage 3b, 4, or 5) and type 2 diabetes for at least 6 months before the screening appointment
- People whose diabetes may be managed with tablets, injections (including insulin or GLP-1 medications), or a combination of these
- People whose treatment plan for any related health conditions has been stable for at least the past 6 months, in the opinion of the study doctor
- People who the study doctor believes are able to give informed consent, follow study instructions, and attend all required visits
- Women who are not able to become pregnant — either because they are aged 50 or older and have been through menopause for at least one year, or because they have had a surgical procedure such as tubal ligation, removal of the ovaries, or a hysterectomy
- Women who could become pregnant, provided they have a negative pregnancy blood test at screening and agree to use an accepted form of contraception from screening until at least 30 days after the last study treatment
Who may not be able to join:
- People who have received treatment for cancer within the past 2 years
- People who are currently pregnant or plan to become pregnant during the study
- People who have used non-prescription opioids or recreational/psychoactive drugs within the past year
- People who have had a severe low blood sugar episode requiring emergency care or treatment (such as glucagon or an intravenous glucose drip) within the past 6 months, unless the study's medical monitor has specifically approved their enrolment
- People who have taken part in another clinical study involving an experimental drug, procedure, or an investigation into blood sugar control methods within the past month
- People who are currently breastfeeding or plan to breastfeed during the study
- People who test positive at screening for HIV, hepatitis B, or hepatitis C
- People whose blood test results at screening show certain abnormal levels — including low red blood cells, low white blood cells, low platelets, or elevated liver-related markers — beyond the thresholds set by the trial (confirm specific values with trial site)
- People who, in the study doctor's opinion, have psychiatric, behavioural, thinking, or other clinical difficulties that could affect their safety or ability to follow the study requirements
- People who are currently receiving dialysis at the time of screening
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sungchun Lee, MD, Arizona Kidney Disease and Hypertension Centers
Phone: 205-612-4763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Estimated Glomular Filtration Rate (eGFR); Blood Urea Nitrogen/Creatinine Ratio (BUN/Cr); Cystatin C; Urine albumin-creatinine ratio (ACR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.